CASC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cascadian Therapeutics Inc's other long-term assets for the quarter that ended in Mar. 2016 was $0.76 Mil.
Cascadian Therapeutics Inc's quarterly other long-term assets declined from Sep. 2015 ($0.52 Mil) to Dec. 2015 ($0.35 Mil) but then increased from Dec. 2015 ($0.35 Mil) to Mar. 2016 ($0.76 Mil).
Cascadian Therapeutics Inc's annual other long-term assets declined from Dec. 2013 ($0.45 Mil) to Dec. 2014 ($0.23 Mil) but then increased from Dec. 2014 ($0.23 Mil) to Dec. 2015 ($0.35 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Cascadian Therapeutics Inc Annual Data
|Other Long-Term Assets||1.53||0.00||0.21||0.15||0.08||0.44||0.51||0.45||0.23||0.35|
Cascadian Therapeutics Inc Quarterly Data
|Other Long-Term Assets||0.45||0.59||0.60||0.45||0.23||0.53||0.52||0.52||0.35||0.76|